Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Rytelo vs. Reblozyl

Head-to-head comparisons of medication uses, side effects, warnings, and more.

  • Rytelo (imetelstat)
    Reblozyl (luspatercept)
  • Rytelo (imetelstat)
    Reblozyl (luspatercept)

  • Summary of Rytelo vs. Reblozyl

    Summary for Telomerase inhibitor
    Prescription only

    Rytelo (imetelstat) is used to treat a blood condition called myelodysplastic syndrome (MDS). It's for adults with lower-risk MDS who also have anemia and need regular red blood cell (RBC) transfusions. Rytelo (imetelstat) is typically used after erythropoiesis‑stimulating agents (ESAs) stop working, don’t work, or can’t be used. It's given as an intravenous (IV) infusion at a clinic once every 4 weeks. Each infusion takes about 2 hours, and you’ll get medications right before to lower the chance of infusion reactions. Common side effects include low platelets, low white blood cells, and feeling tired.

    Summary for Biologic
    Prescription only

    Reblozyl (luspatercept or luspatercept-aamt) is an injectable medication used to treat anemia (low red blood cells) in adults with beta thalassemia or certain myelodysplastic syndromes (MDS) who require regular red blood cell transfusions. Reblozyl (luspatercept) is given by a healthcare provider every 3 weeks.

  • Indications of Rytelo vs. Reblozyl

    Indications for
    •Lower-risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
    Indications for
    •Anemia in adults with beta thalassemia who require regular red blood cell (RBC) transfusions
    •Anemia in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who can't receive an erythropoiesis stimulating agent (ESA) and need regular RBC transfusion

  • Pros and Cons of Rytelo vs. Reblozyl

    Pros and Const for Telomerase inhibitor
    Pros
    •Shown to reduce or stop the need for RBC transfusions for many people with lower‑risk MDS
    •An option for people who already tried erythropoiesis‑stimulating agents (ESAs) or can't use them
    •Given once every 4 weeks at a clinic, so no at‑home mixing or injections
    Cons
    •Can raise your risk of easy bleeding and infection
    •Requires frequent blood tests to check for safety, especially early in treatment
    •Must stay at the clinic for at least 1 hour after the infusion ends so your care team can check for infusion reactions
    Pros and Const for Biologic
    Pros
    •Treatment is every 3 weeks
    •Can lower the need for RBC transfusions
    •Dose is individualized for each person
    Cons
    •Not approved for children
    •Has to be given by injection
    •Can't give yourself the injection; must be given by a provider

  • Common Side Effects of Rytelo vs. Reblozyl

    Common Side Effects for
    •Drop in platelet count (97%)
    •Drop in white blood cell count (94%)
    •Higher liver enzyme levels (up to 55%)
    •Feeling tired (29%)
    •Joint or muscle aches (25%)
    Common Side Effects for
    •Tiredness (14-41%)
    •Headache (14-26%)
    •Muscle or bone pain (20%)
    •Joint pain (19%)
    •Dizziness (11-18%)
    •Nausea (9-16%)
    •Diarrhea (12-16%)
    •Cough (14%)
    •Stomach pain (14%)
    •Difficulty breathing (13%)
    •Allergic reaction (10%)

  • Warnings of Rytelo vs. Reblozyl

    Common Side Effects for
    •Low platelets
    •Low white blood cells
    •Infusion-related reactions
    •Harm to an unborn baby
    Common Side Effects for
    •Blood clots
    •High blood pressure
    •Harm to unborn baby

  • Prices with our coupons for Rytelo vs. Reblozyl

    Learn more about Rytelo
    Learn more about Reblozyl

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.